Rhagolwg
My research focuses on the design, synthesis and biological evaluation of novel therapeutic and diagnostic agents across infectious diseases, oncology and neurodegeneration. I have extensive expertise in synthetic organic chemistry, medicinal chemistry, natural product–inspired drug discovery, and structure–activity relationship (SAR) development. My work spans the synthesis of new antibiotics, antituberculosis agents, kinase inhibitors for triple‑negative breast cancer, antitrypanosomal compounds for Chagas disease, and antiviral candidates targeting CHIKV. I also develop next‑generation diagnostic tools for neurodegenerative diseases through chemical antibody technologies in collaboration with leading UK and international partners.
Cymwysterau
- BSc: Pharmaceutical Sciences
Aleppo University, - Profesiynol: Fellowship in teaching, Advance HE
Higher Education Academy, - MSc: Medicinal Chemistry
University of Paris-Sud, - PhD in Medicinal Chemistry
University of Paris-Sud, - Profesiynol: The Postgraduate Certificate in Higher Education Teaching (PGCHET)
University of Sussex,
Addysgu ac Arolygiaeth
She is proud to hold a Fellowship with the UK Higher Education Academy (FHEA), a recognition of her dedication to high-quality teaching and learning. This accreditation has shaped her approach to curriculum design, assessment strategies, small-group teaching, and undergraduate research supervision. She has extensive experience in developing and delivering innovative MPharm and MSc programs, with a strong emphasis on inclusive education, study skills enhancement, and career development support for both domestic and international students. At Bangor, she teaches chemistry in the Mpharm program (MSE-0012, MSE-1033-MSE-1034, MSE-1036 and MSE-0013), leads module MSE-0013, and serves as the Foundation Year Lead.
Hadia is currently supervising undergraduate research projects and welcomes undergraduate students to apply.
Diddordebau Ymchwil
Hadia is leading the research in Medicinal Chemistry at Bangor University, her research focuses on the design, synthesis and biological evaluation of novel therapeutic and diagnostic agents across infectious diseases, oncology and neurodegeneration. She has extensive expertise in synthetic organic chemistry, medicinal chemistry, natural product–inspired drug discovery, and structure–activity relationship (SAR) development. Her work spans the synthesis of new antibiotics, antituberculosis agents, kinase inhibitors for triple‑negative breast cancer, antitrypanosomal compounds for Chagas disease, and antiviral candidates targeting CHIKV. She also develop next‑generation diagnostic tools for neurodegenerative diseases through chemical antibody technologies in collaboration with leading UK and international partners.
Cyfleoedd Project Ôl-radd
1- Design and synthesis of new anticancer drugs
2- Design and synthesis of neurodegenerative diseases treatment
3- Design and synthesis of new antivirals
In addition to working on high quality research projects in Hadia’ s Research group, you will gain a strong set of skills and experiences that significantly enhance their academic and professional development. This includes:
• Hands on experimental training in both chemistry and biology
• Practical experience in molecular design, from analysing protein structures to designing ligands with improved binding and selectivity
• Exposure to real drug discovery workflows, moving from conceptual design to synthesis, biological testing, and data interpretation
• Opportunities to connect theoretical knowledge with real therapeutic challenges, strengthening scientific reasoning and problem solving
• The chance to contribute to high quality, publishable research, building a strong academic profile
• A solid foundation for future PhD or postdoctoral applications, as well as careers in the pharmaceutical industry, biotechnology, or research laboratories
Students in this group don’t just learn techniques, they develop the mindset and skillset of modern drug discovery scientists.
Blaenorol
To share her research and engage with the global scientific community, she has participated in over 45 international conferences and symposiums across Europe, Japan, the UK, the UAE, Egypt, and Syria. She actively contributes to scholarly publishing as a regular reviewer for leading Q1 journals such as Frontiers in Chemistry, Journal of Drug Delivery Science and Technology, International Journal of Biological Macromolecules, and various MDPI journals. She has been recognized as a trusted reviewer and currently serve on the editorial board of the Archive of Advanced Chemistry Journal, as well as a guest editor for MDPI journals.
Beyond academia, she’s passionate about making science accessible to younger generations. As a STEM ambassador, she actively supports school outreach initiatives, inspiring future scientists and promoting engagement with the pharmaceutical sciences